Eficácia das vacinas e perfil epidemiológico da COVID-19 em crianças
DOI:
https://doi.org/10.34119/bjhrv6n1-030Keywords:
vacinação, efeitos adversos, crianças, Covid-19, perfil epidemiológicoAbstract
A vacinação infantil é de extrema importância em um contexto pandêmico mundial, haja vista o crescente número de infectados e de óbitos pela doença. Muitos pais se tornaram resistentes aos planos de imunização, uma vez que as Fake News não facilitaram o processo de conscientização da população. Mesmo com essas especulações sobre a eficácia e segurança das vacinas, essas são comprovadamente confiáveis em todos os aspectos, salvo em raros casos de miocardite. Ainda assim, a vacina é o meio mais seguro de se passar pela pandemia, uma vez que os relatos de ocorrência de SIM-P em crianças que contraíram a doença são mais comuns que os casos de efeitos adversos provocados pelas vacinas. Assim, tem-se como objetivo desde artigo, tratar sobre a eficácia das vacinas contra a Covid-19 em crianças, bem como apresentar o perfil epidemiológico da doença, através de uma pesquisa documental realizada na ESF de Paranapuã, interior de São Paulo, e também de revisões bibliográficas detalhadas. Os resultados obtidos indicam que a população infantil evolui com menos frequência para estados críticos/óbitos da doença provocada pelo SARS-CoV-2. Dessa forma, conclui-se que a imunização infantil, independente da marca da vacina, é indispensável. Ademais, como já foi provado a eficácia e segurança das vacinas pediátricas, é mais benéfico receber a vacina e evitar o agravamento da doença do que manter a chance de ser infectado e possuir sequelas posteriormente.
References
- Home – Butantan Institute [Internet]. Covid-19 is the second leading cause of death in children; see the infographic and understand the importance of vaccination; [cited 27 May 2022]. Available from: https://butantan.gov.br/noticias/covid-19-e-a-segunda-causa-de-morte-em-criancas--veja-o-infografico-e-entenda-a-importancia-da-vacinacao
- Pereira Soares da Silva Damasceno D, Cerqueira Santos Santana da Silva A, Fernandes Portela L, Garcia Bezerra Góes F, Araujo Martinez E, de Lima Neves G. Epidemiological Profile of Children Infected by the New Coronavirus: Cross-Sectional Study. Cogitare Enfermagem. 2022;27(82798).
- Lv M, Luo X, Shen Q, Lei R, Liu X, Liu E, Li Q, Chen Y. Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Children and Adolescents: A Systematic Review. MDPI. 29 set 2021;9(10).
- Kroll R. Arco Magazine [Internet]. Is childhood vaccination against Covid-19 safe?; [cited 27 May 2022]. Available from: https://www.ufsm.br/midias/arco/vacinacao-infantil-covid-19-segura/#:~:text=Reações%20e%20efeitos%20adversos%20da%20vacina%20infantil&text=O%20CDC%20constatou%20que,%20dentre,fadiga%20ou%20dor%20de%20cabeça
- Singh S, Sharma BB. Severe acute respiratory syndrome-coronavirus 2 and novel coronavirus disease 2019: an extraordinary pandemic. Lung India. 2020;37(3):268-71. doi: 10.4103/lungindia.lungindia_170_20 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Nascimento IJB, Cacic N, Abdulazeem HM, Groote TC von, Jayarajah U, Weerasekara I, et al. Novel Coronavirus Infection (COVID-19) in Humans: a scoping review and meta-analysis. J Clin Med. 2020;9(4):941. doi: 10.3390/jcm9040941 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51-60. doi: 10.21037/tp.2020.02.06 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 Infection in Children. New England J Med. 2020;382(17):1663-5. doi: 10.1056/ NEJMc2005073 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Nunes J. The COVID-19 pandemic: securitization, neoliberal crisis, and global vulnerabilization. Cad Saúde Pública. 2020;36(5). doi: 10.1590/0102-311x00063120 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Pan-American Health Organization (PAHO). Information sheet - COVID-19 (disease caused by new coronavirus) [Internet]. 2020 [cited 2020 May 23]. Available from: https://www.paho.org/bra/index.php?option=com_content&view=article&id=6101:covid19&Itemid=875 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. doi: 10.1016/S0140-6736(20)30566-3 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- World Health Organization (WHO). Multisystem inflammatory syndrome in children and adolescents with COVID-19: Scientific Brief [Internet]. 2020 [cited 2020 May 15]. Available from: https://www.who.int/publications-detail/ multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-1 apud Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Bernardino FBS, Alencastro LCS, Silva RA, Ribeiro ADN, Castilho GRC, Gaíva MAM. Epidemiological profile of children and adolescents with COVID-19: a scoping review. Rev Bras Enferm. 2021;74(Suppl 1):e20200624. doi: http://dx.doi.org/10.1590/0034-7167-2020-0624
- Li R, Pei S, Chen B, Song Y, Zhang T, Yang W, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science. 2020;368:489-93 apud Safadi MA. The intriguing features of COVID-19 in children and its impact on the pandemic. J Pediatr (Rio J). 2020;96:265-8
- Ferguson NM, Laydon D, Nedjadi-Gilani G, Imai N, Ainslie K, Baguelin M, et al. Report 9: impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imperial College COVID-19 Response Team; 2020. Available from: https://doi.org/10.25561/77482 [cited 02.04.20] apud Safadi MA. The intriguing features of COVID-19 in children and its impact on the pandemic. J Pediatr (Rio J). 2020;96:265-8
- Home - Butantan Institute [Internet]. CoronaVac shows high efficacy and safety in children aged 6 months to 17 years in phase 3 studies around the world; [cited 3 June 2022]. Available from: https://butantan.gov.br/noticias/coronavac-mostra-alta-eficacia-e-seguranca-em-criancas-de-seis-meses-a-17-anos-em-estudos-de-fase-3-pelo-mundo
- Nehab MF. Covid-19 and child and adolescent health. Rio de Janeiro: Fiocruz; 2020 [access 19 Aug. 2021]. Available form: https:// portaldeboaspraticas.iff.fiocruz.br/atencao-crianca/ covid-19-saude-crianca-e-adolescente apud Lima EJ, Faria SM, Kfouri RD. Reflections on the use of vaccines for Covid-19 in children and adolescents. Epidemiology and health services [Internet]. 2021 [cited 3 June 2022];30(4). Available from: https://doi.org/10.1590/s1679-49742021000400028
- Osmanov IM, Spiridonova E, Bobkova P, Gamirova A, Shikhaleva A, Andreeva N, et al. Risk factors for long covid in previously hospitalised children using the ISARIC global follow-up protocol: a prospective cohort study. medRxiv. 2021. doi: https://doi.org/10.1101/2021.04.26.21256110 . Now published in Eur Respir J. doi: https://doi. org/10.1183/13993003.01341-2021 apud Lima EJ, Faria SM, Kfouri RD. Reflections on the use of vaccines for Covid-19 in children and adolescents. Epidemiology and health services [Internet]. 2021 [cited 3 June 2022];30(4). Available from: https://doi.org/10.1590/s1679-49742021000400028
- Ministry of health (BR). Disease by the new coronavirus: Covid-19. Bol Epidemiol. 12-18 Sep. 2021[access 26 Sep 2021];(81). Available from: https://www.saude.gov.br apud Lima EJ, Faria SM, Kfouri RD. Reflections on the use of vaccines for Covid-19 in children and adolescents. Epidemiology and health services [Internet]. 2021 [cited 3 June 2022];30(4). Available from: https://doi.org/10.1590/s1679-49742021000400028
- Fiocruz [Internet]. Covid-19: Fiocruz publishes results of the VacinaKids study; [cited 3 June 2022]. Available from: https://portal.fiocruz.br/noticia/covid-19-fiocruz-divulga-resultados-do-estudo-vacinakids
- Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine 2015;33:4398–405. PMID:26209838 https://doi.org/10.1016/j.vaccine.2015.07.035 apud HAUSE, Anne M. et al. COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021. MMWR. Morbidity and Mortality Weekly Report, v. 70, n. 5152, p. 1755-1760, 31 dez. 2021. Disponível em: https://doi.org/10.15585/mmwr.mm705152a1. Access: 3 June. 2022.
- HAUSE, Anne M. et al. COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021. MMWR. Morbidity and Mortality Weekly Report, v. 70, n. 5152, p. 1755-1760, 31 Dec. 2021. Available from: https://doi.org/10.15585/mmwr.mm705152a1. Access: 3 June. 2022.
